Sign in


Image for post
Image for post
Moving quickly to get COVID-19 therapeutics into the clinic, the U.S. Food and Drug Administration (FDA) recently granted emergency approval to two antibody treatments for COVID-19, developed by Eli Lilly and Regeneron. The drugs generally contain one or more disease-fighting proteins called monoclonal antibodies that mimic those made by the human immune system. So far, they are proving safe, making researchers even more optimistic about the potential of lab-made antibodies to prevent and treat SARS-CoV-2 infections.


Image for post
Image for post

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store